{
    "organizations": [],
    "uuid": "46eed7c184f1364dc3813a9f10c46eac4166e84f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aldeyra-therapeutics-announces-fir/brief-aldeyra-therapeutics-announces-first-patient-enrolled-in-dry-eye-disease-phase-2b-clinical-trial-idUSASB0C2Z5",
    "ord_in_thread": 0,
    "title": "BRIEF-Aldeyra Therapeutics Announces First Patient Enrolled In Dry Eye Disease Phase 2B Clinical Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Aldeyra Therapeutics Inc:\n* ALDEYRA THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN DRY EYE DISEASE PHASE 2B CLINICAL TRIAL Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T21:12:00.000+02:00",
    "crawled": "2018-01-31T16:19:08.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "aldeyra",
        "therapeutic",
        "inc",
        "aldeyra",
        "therapeutic",
        "announces",
        "first",
        "patient",
        "enrolled",
        "dry",
        "eye",
        "disease",
        "phase",
        "2b",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}